Norfloxacin is not typically recommended for pediatric use due to limited safety and efficacy data in children. The U.S. Food and Drug Administration (FDA) has not approved its use in individuals under 18 years of age. In specific circumstances, such as when no alternative treatment is available, a healthcare provider might consider its use in older children and adolescents under close supervision.
